Search

everythinglearnresearchcommunity

for

Search:↓

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

New understanding and treatments for hair loss are improving, but more research is needed.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Autologous cell-based therapies, especially SVF, effectively and safely improve atrophic acne scars.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

C4BPA protein may link acne severity and insulin resistance.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Ascorbic acid derivatives improve drug delivery systems.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Nanocarriers can make acne treatments more effective and gentle on the skin.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Menopause-related skin changes may increase fungal infections and inflammation.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Long-COVID has diverse, long-term health impacts, especially in young people.

The model and estimator can predict drug exposure in kidney transplant patients well.

Alopecia areata greatly affects people's life quality, mental health, and work life.

"HairSentinel" accurately detects hairfall trends using simple user data, helping identify health risks early.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.